Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.

Osmetech : The Next Generation - Info and Links thread. (OMH)     

DITCHPIG - 30 Apr 2004 15:09

omhnew4vo.gifomhlogo24kn.gifomhnew4vo.gifomhbot8kj.gif

UBS AG buy 8,825,000 6.7%

eSensor LAUNCHED!!!

FDA clearance for Cystic Fibrosis DNA Test

Sales of the eSensor instrument and CF test will commence in the first half of 2006 as planned.. .

James White, CEO of Osmetech said:

'Gaining FDA clearance for our first microarray based test developed for our new eSensorTM molecular diagnostics instrument is a major step forward for our Molecular Diagnostics Division and will help to establish Osmetech as a key player in the fast growing moleculardiagnostics market. In addition, this FDA clearance helps to validate our microarray technology for routine use in the laboratory.

Critical Care DivisionThe Division has a strong product portfolio and is well placed to continue the growth of instrument placements throughout the world, leading to revenues from proprietary consumables for a number of years to come.Sales of OPTI instruments and consumables remained strong resulting from increased sales of the new touchscreen version of the long-established OPTI (CCA). In 2006 we will start to see an important contribution to sales from the new OPTI LION portable electrolyte analyser and the OPTI R blood gas and electrolyte analyser with reusable consumable as these products are rolled out internationally.'

Molecular Diagnostics DivisionFollowing FDA approval of the eSensorTM platform Osmetech are now looking to progress discussions with strategic partners who are looking for cost effective and easy to use instrumentation and consumables to work on other complex assays both in the healthcare and non healthcare markets. The next Osmetech Molecular test targeted for FDA submission will be the CYP 450 pharmacogenomics assay, which is currently in development.

James White, CEO of Osmetech commented:

'We have been delighted with the rapid integration of the CMS business acquired in July. The powerful combination of the eSensor product together with OPTI GENE provides Osmetech Molecular Diagnostics with an excellent position in this rapidly developing and growing market sector. Both products remain on schedule for launch and revenue generation in the first half of 2006'

Sales to year end up over 40%

Osmetech has reported a strong rise in sales in the latter part of 2005 with growth driven byabove-forecast revenues at its Critical Care blood gas analysis division.. Sales for the Critical Care division in calendar year 2005 exceeded $14.7m, representing an increase of over 60% compared to the calendar year 2004. Approximately half of this overall growth is due to sales to veterinary distribution partner, IDEXX Laboratories, Inc.

Vetstat Exceeds Idexx Expectations

Sales of the VetStat electrolyte and blood gas analyser have been very encouraging and continue to exceed expectations. IDEXX's sales successes and continuing marketing efforts should result in further strong growth for the foreseeable future. As the installed base of instruments becomes established, revenues from proprietary consumables are expected to increase as a proportion of this veterinary business. Following a deal with leading US vetinary hopsital chain Banfield, Idexx are contracted to supply an additional 450 Vetstat devices over the coming year.Good progress is also being made with IDEXX on the development and supply contract to create a new platform for measuring critical care parameters based on Osmetech's proprietary optical fluorescence technology and consumables. It is anticipated that this market leading product is on target for launch late 2006/2007.

Critical Care Product Range - In Production

OPTI-CCA Opti CCA. Sales revenues for this product and consumables were in excess of $14,000,000 in 2005. More than 5000 units are in use worldwide.OPTI-LION Opti Lion. Newly launched in late 2005 this device competes head on with more complex systems. Significant sales are forcast for 2006/7OPTI-R Opti R. Newly launched in late 2005 the OPTI R is a compact blood gas analyzer using a combination of proven maintenance-free sensor technology, intuitive graphic user interface and automated system monitoring to increase operator convenience and reduce time spent on blood gas testing while delivering fast reliable results.OPTI-2L Opti 2 Line. Designed for portability, the Osmetech OPTI Analyzer is always ready for testing wherever you need it for measurement of pH/blood gas, total hemoglobin, oxygen saturation, electrolytes and glucose.

Critical Care Consumable Product Range - In Production

SamplerComfort Sampler. Launched in July 2004 this product, has become the arterial blood sampling method most preferred by therapists and patients. Sales are expected to generate revenues in excess of $2,000,000.Cassette Sensor Cassette. Over 4000 tests per day are made using Opti consumables generating revenues in excess of $8,000,000Callibration The calibration gas bottle assures accurate calibration prior to each sample measurement.DataTrolData Management Software. Consolidate test results in one centralized location

Molecular Diagnostics Product Range - In Production

Opti-GeneOpti-Gene. The system allows for the detection of DNA and RNA targets using PCR or RT-PCR based assays in hospital and clinical research laboratories. Lauching in May first test will be for Factor V Leiden MutationeSensoreSensor. a low cost instrument and consumable for moderately complex genetic testing where the detection of multiple gene targets is required. Initally tests will be for cystic fibrosis and CYP450.BiochipBiochip. Single use bio-chip disposable cartridge for use in the eSensor device.ConsumableConsumables. Disposable cartridge for use in the eSensor device.OPTI Tube OPTI Tube Primary consumable for the OPTI Gene and compatible with the large installed base of LightCycler instrument. Launching from May

Product Range - Licenced to Third Party

VetStat VetStat Based on the OPTI-CCA device. This instrument is being sold in to the vetinary market by industry leading corporation IDEXX. Considerable sales are being made Cassettes Cassette : The only blood gas system calibrated for veterinary-specific reference ranges. An increasing range producing substantial sales. Being sold by Idexx for the Vetstat deviceOPTI Tube OPTI Tube Licensed to Roche to manufacture and sell plastic consumable vials for use on its large installed base of LightCycler instruments. Osmetech plans to manufacture and sell the plastic consumable vials as an alternative to glass vials itself. Sales are anticipated to start early 2006 AVOX 4000 AVOX 4000 The AVOXimeter 4000 provides a fast, accurate assessment of patient oxygenation at the bedside. Sold worldwide (-usa) by Osmetech in a deal with Avox

Buisness Partners
idexxlogo.gifroche_logo.giflogo.gifsysmex_logo.jpg

Major Shareholders
Organisation Shareholding % Gartmore 24,109,657 18.29% Schroder 18,874,284 14.32 UBS AG 8,825,000 6.70TD Waterhouse 7,011,137 5.32 Barclays Nom 6,638,092 5.04 Pershing Keen 5,870,773 4.45HSBC Global Nom 6,544,718 4.97 Roche 2,444,688 1.8 Marlborough UK Micro Cap Director Holdings James White 208,092 Gordon Hall 104,966 D Sandilands 61,597 GB Kuenster 33,054 A Marek 26,190 ADVFN Posters 5,896,564 4.5 Total Holdings 86,648,812 65.7%

Mouse Over Images For Product Data
backup_counter.cgi?counter_id=644347updater.cgi?counter_id=644347&increment=If regular posters would like to be included in the ADVFN figure and if you are not bothered about the figures being public then post your long-term holding here.IE the number of shares you intend to keep for say more than 6 months?Alternatively if you'd rather keep your holdings secret but still want contribute to the overall figure then drop me a line to ditchpig@ntlworld.com

DITCHPIG - 09 Dec 2005 12:22 - 229 of 242

The Osmetech website has been update. All mention of the enose has been removed. Guess its finally dead then!

http://www.osmetech.com

The company also has a bust year ahead of it. Osmetech products are being launched / displayed at 12 exhibitions next year.

http://www.osmetech.com/exhibits.htm

DITCHPIG - 19 Dec 2005 07:28 - 230 of 242

Found this interesting little PDF about the OPTI-CCA.
It gives some more close up detail and information on how it works and a list of the some of the organisations in the UK using it.
Interstingly BUPA have 17 of them, perhaps there is great potential here for pushing the rest of Osmo product line.


http://www.bio-stat.com/files/downloads/26.pdf

Interestingly Gordon Hall was previously a director of Biostat and nodoubt will maintain connections with them.

Osmetech GMBH are starting to get a little more exposure as well.
http://www.notfalllabor.de/Osmetech-GmbH/40-0-0-0-94-0-0-O.html

panic - 29 Dec 2005 15:18 - 231 of 242

Nice rise today have I missed some news?

DITCHPIG - 03 Jan 2006 10:32 - 232 of 242

No not yet but if you don't get in quick you could well do.
Osmetech have moved their year end to 31/12 so a trading statement is expected real soon.
Also news from the FDA re the Cystic Fibrosis test is due at any time.
So still time to grab a piece of the action before then. Still you could always hold on to them as the company are launching a number of products this both independantly and with partner in vetinary diagnostics Idexx.

DITCHPIG - 20 Mar 2006 13:50 - 233 of 242

Results Out On Tuesday

DITCHPIG - 20 Mar 2006 13:50 - 234 of 242

Investors Chronicle says Good Value BUY

DITCHPIG - 20 Mar 2006 13:51 - 235 of 242

eSensor gets a new set of clothes. How sexy is that. Wouldnt look out of place on the starship enterprise.
Bewarned these images are massive and will give your internet connection a kicking.
I said in an earlier posting that I thought esensor might be delayed. Well I take that back. This is the make over I was expecting to see before launch. These are publicity shots from 8 days ago. Get them while there hot!

http://tech-dimensions.com/osmetech/Pics/Image_0224.JPG

New consumables for eSensor.
http://tech-dimensions.com/osmetech/Pics/Image_0245.JPG

Rest of the pics here.

http://tech-dimensions.com/osmetech/Pics/



Osmetech GMBH are now selling the AVOX4000 in addition to the other Osmo products. This core division in the Osmetech

sales push is starting to grow very nicely.
http://www.notfalllabor.de/Osmetech-GmbH/40-0-0-0-94-0-0-O.html

Osmetech GMBH are also exhibiting at the
47. KONGRESS DER DEUTSCHEN GESELLSCHAFT F PNEUMOLOGIE .
This meeting is not listed on Osmo website.
http://www.dgp2006.de/index.php?Auswahl=Industrie&Menue=Ebene0

Want to know how much OPTI bits cost? Well looky here.
http://www.surrey.ac.uk/MHRA/Pages/GuildfordEvaluations/CurrentReports/BloodGas/Blood%20gas%20pdfs/Osmetech%20OPTI%20CCA.pdf

Think you're clever? Have a go at debugging some of the code that drives opti.
http://nickhennenfent.com/gasgauge.c.htm

I think there can be little doubt now that Osmo are going to push their DNa technology in to the Vetinary market.
Yet another senior scientist is being recruited for this role.
http://www.socalbio.org/career_center/open-position/OMDJD_Sr[1]._Scientist.doc


This one is interesting. It makes reference to "management of an outside contractor developing a large software project." I wonder what that large software project could be.

http://www.socalbio.org/career_center/open-position/OMDJD_Sr[1]._Software_Eng.DOC


News link to Southern California Biomedical Council. eSensor to start full scale manufacturing in the spring. From the pics above looks like it already has!

http://www.socalbio.org/newsletter/spring2006/Synergies_Spring_2006.pdf


Looks like the recent Arab Health event sporned a new buisness relationship.
http://www.arabhealthonline.com/index.cfm?page=exhibitor_details&menuid=&RecordNo=1&id=4659&type=alphabet&c=O&option=&keyword=&style=1

http://www.transemirate.com/osmetech.htm

Presumably the opTIT device mentioned on the site a special version modifed for those of a poisson persuasion.

And the caribbean.
http://www.andarint.com/manufacturer_osmetech.php
And Norway.
http://www.mednett.no/english/blodgass_uk.html

DITCHPIG - 23 Mar 2006 12:12 - 236 of 242

update with gartmore holding

DITCHPIG - 24 Mar 2006 13:27 - 237 of 242

Investors Chronicle says Good Value BUY

DITCHPIG - 04 Apr 2006 14:10 - 238 of 242

Updated with the most recent shareholder infiormation.

bangersmam - 04 Apr 2006 17:50 - 239 of 242

1,300,00 BUY just before close = c300,000 investment!

bangersmam - 23 Apr 2006 09:38 - 240 of 242

OMH (Osmetech) Tipped as a BUY in todays Sunday Telegraph
Sunday Telegraph (UK) - Apr. 23, 2006

KEEP an eye on Osmetech, the healthcare diagnostics group (24p).

Under the stewardship of James White, the company has developed into a business with sales, mainly thanks to a handful of acquisitions.

In results published last month, Osmetech revealed that sales for the eight months to December 31 were up by 78 per cent on the corresponding period.

Its investment in its critical care business is also paying off, with sales up by 64 per cent to $14.8m ( pounds 8.3m).

Since then it has announced the launch of its eSensor cystic fibrosis carrier detection (CFCD) test and its eSensor 4800 DNA detection instrument.

The eSensor system can be used to perform molecular tests that require the simultaneous analysis of multiple genetic information. Product shipments are expected to begin on schedule during the first half of this year, the company said.

We believe the shares look like good value. Buy.

spaceshuttlesmall5jr.gif

bmw325 - 23 Apr 2006 19:26 - 241 of 242

The fuse has been lit...

DITCHPIG - 26 Apr 2006 21:20 - 242 of 242

Updated with new shareholder data.
Register now or login to post to this thread.